BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Healthtrust
Cipla
US Department of Justice
Federal Trade Commission
UBS
Citi
Deloitte
Dow
Cantor Fitzgerald

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074425

« Back to Dashboard

NDA 074425 describes PENTOXIFYLLINE, which is a drug marketed by Actavis Elizabeth, Apotex, Heritage Pharms Inc, Impax Labs, Mylan, Pliva, Teva, Valeant Pharms, and Watson Labs, and is included in nine NDAs. It is available from twenty suppliers. Additional details are available on the PENTOXIFYLLINE profile page.

The generic ingredient in PENTOXIFYLLINE is pentoxifylline. There are fourteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
Summary for 074425
Tradename:PENTOXIFYLLINE
Applicant:Mylan
Ingredient:pentoxifylline
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 074425
Suppliers and Packaging for NDA: 074425
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PENTOXIFYLLINE pentoxifylline TABLET, EXTENDED RELEASE;ORAL 074425 ANDA Mylan Pharmaceuticals Inc. 0378-0357 0378-0357-05 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0378-0357-05)
PENTOXIFYLLINE pentoxifylline TABLET, EXTENDED RELEASE;ORAL 074425 ANDA Mylan Pharmaceuticals Inc. 0378-0357 0378-0357-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0378-0357-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength400MG
Approval Date:Jul 8, 1997TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
QuintilesIMS
Deloitte
Argus Health
Fish and Richardson
Medtronic
Merck
Novartis
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot